Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Global Medical REIT ( (GMRE) ) has issued an update.
On September 18, 2025, Global Medical REIT Inc. implemented a one-for-five reverse stock split, reducing its authorized common stock from 500 million to 100 million shares. This adjustment, effective September 19, 2025, did not affect the company’s preferred stock or shareholders’ ownership percentages, except for minor changes due to fractional shares being settled in cash. The common stock will trade on a split-adjusted basis on the NYSE from September 22, 2025.
The most recent analyst rating on (GMRE) stock is a Hold with a $7.50 price target. To see the full list of analyst forecasts on Global Medical REIT stock, see the GMRE Stock Forecast page.
Spark’s Take on GMRE Stock
According to Spark, TipRanks’ AI Analyst, GMRE is a Neutral.
Global Medical REIT’s overall score is driven by strong financial performance and strategic growth initiatives highlighted in the earnings call. However, high P/E ratio and dividend reduction pose valuation concerns. Technical indicators suggest neutral momentum, balancing the overall assessment.
To see Spark’s full report on GMRE stock, click here.
More about Global Medical REIT
Global Medical REIT Inc. is a net-lease medical real estate investment trust (REIT) that acquires healthcare facilities and leases them to physician groups and regional and national healthcare systems.
Average Trading Volume: 731,977
Technical Sentiment Signal: Buy
Current Market Cap: $553M
For an in-depth examination of GMRE stock, go to TipRanks’ Overview page.